Placental mesenchymal dysplasia associated with hepatic mesenchymal hamartoma in the newborn

Pediatric and Developmental Pathology

Volumn 10, Issue 1, 2007, Pages 50-54

  Francis, Babu ^c   Hallam, Lavinia ^a,b   Kecskes, Zsuzsoka ^a,b   Ellwood, David ^a,b   Croaker, David ^a,b   Kent, Alison ^a,b  

^a CANBERRA HOSPITAL   (Australia)

^b Canberra Hospital   (Australia)

^c NONE

Author keywords

Hamartoma; Hepatic; Mesenchymal dysplasia; Newborn; Placenta; Preterm labor

Indexed keywords

ABDOMINAL MASS; ARTICLE; AUTOPSY; BLOOD CLOTTING DISORDER; BRAIN DISEASE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CASE REPORT; CAUSE OF DEATH; CRITICALLY ILL PATIENT; DISEASE ASSOCIATION; FEMALE; FETUS DISTRESS; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LIVER BIOPSY; LIVER CYST; LIVER MESENCHYMAL HAMARTOMA; LIVER TUMOR; NEWBORN; PLACENTA DISORDER; PLACENTA MESENCHYMAL DYSPLASIA; PREMATURE LABOR; PRIORITY JOURNAL; TISSUE SECTION; ECHOGRAPHY; FETUS DISEASE; HAMARTOMA; LIVER DISEASE; MESODERM; PATHOLOGY; PLACENTA; PREGNANCY; PREMATURITY;

FEMALE; FETAL DISEASES; HAMARTOMA; HUMANS; INFANT, NEWBORN; LIVER DISEASES; MESODERM; OBSTETRIC LABOR, PREMATURE; PLACENTA; PLACENTA DISEASES; PREGNANCY; PREMATURE BIRTH; ULTRASONOGRAPHY, PRENATAL;

EID: 34247853510     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/06-03-0066.1     Document Type: Article

References (33)

1. Ohyama M, Kojyo T, Gotoda H, Sato T, Ijiri R, Tanaka Y. Mesenchymal dysplasia of the placenta. Pathol Int 2000;50:759-764.
2. Chan YF, Sampson A. Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole. Aust N Z J Obstet Gynaecol 2003;43:475-479.
3. Jauniaux E, Nicolaides KH, Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta 1997;18:701-706.
4. Kuwabara Y, Shima Y, Araki T, Shin S. Mesenchymal stem villous hyperplasia of the placenta and fetal growth restriction. Obstet Gynaecol 2001;98:940-943.
5. Furuhashi M, Oda H, Nakashima T. Hydrops of placental stem villi complicated with fetal congenital adrenal hyperplasia. Arch Gynecol Obstet 2000;264:101-104.
6. Paradinas FJ, Sebire NJ, Fisher RA, et al. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology 2001;39: 447-454.
7. Laberge JM, Patenaude Y, Desilets V, et al. Large hepatic mesenchymal hamartoma leading to mid-trimester fetal demise. Fetal Diagn Ther 2005;20:141-145.
8. Gibson BR, Muir-Padilla J, Champeaux A, Suarez ES. Mesenchymal dysplasia of the placenta. Placenta 2004;25:671-672.
9. Matsui H, Iitsuka Y, Yamazawa K, et al. Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol Int 2003;53:810-813.
10. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006;43:187-192.
11. Sander CM. Angiomatous malformation of placental chorionic stem vessels and pseudo-partial molar placentas: report of five cases. Pediatr Pathol 1993;13:621-633.
12. Murray JD, Ricketts RR. Mesenchymal hamartoma of the liver. Am Surg 1998;64:1097-1103.
13. Yen JB, Kong MS, Lin JN. Hepatic mesenchymal hamartoma. J Paediatr Child Health 2003;39:632-634.
14. Arfa MN, Gharbi L, Zaqfrani MR, et al. Cystic mesenchymal hamartoma of the liver report of a case and review of the literature. Hepatogastroenterology 2004;51:ccxlix-ccli.
15. Fuchs J, Schweinitz DV, Feickert HJ. Acute respiratory distress syndrome following resection of a mesenchymal hamartoma of liver. Med Pediatr Oncol 1999;32:151-153.
16. Alwaidh MH, Woodhall CR, Carty HT. Mesenchymal hamartoma of the liver: a case report. Pediatr Radiol 1997;27:247-249.
17. Kitano Y, Ruchelli E, Weiner S, Adzick NS. Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta. Fetal Diagn Ther 2000;15:134-138.
18. Tobvin J, Segal M, Tavori I, Lotan G, Maymon R. Hepatic mesenchymal hamartoma: a pediatric tumor that may be diagnosed prenatally. Ultrasound Obstet Gynecol 1997;10:63-65.
19. Foucar E, Williamson RA, Yiu-Chiu V, Varner MW, Kay BR. Mesenchymal hamartoma of the liver identified by fetal sonography. Am J Roentogenol 1983;40:970-972.
20. Speleman F, De Telder V, De Ptter KR, et al. Cytogenetic analysis of a mesenchymal hamartoma of the liver. Cancer Genet Cytogenet 1989; 40:29-32.
21. Mascarello JT, Krous HF. Second report of a translocation involving 19q13.4 in a mesenchymal hamartoma of the liver. Cancer Genet Cytogenet 1992;58:141-142.
22. Bove KE, Blough RI, Soukop S. Third report of t(19q)(13.4) in mesenchymal hamartoma of the liver with comments on link to embryonal sarcoma. Pediatr Dev Pathol 1998;1:438-442.
23. O'Sullivan MJ, Swanson PE, Knoll J, Taboada EM, Dehner LP. Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol 2001;4:482-489.
24. Murthi GVS, Paterson L, Azmy A. Chromosomal translocation in mesenchymal hamartoma of the liver: what is its significance? J Pediatr Surg 2003;38:1543-1545.
25. Rakheja D, Margraf LR, Tomlinsons GE, Schneider NR. Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality. Cancer Genet Cytogenet 2004;153:60-63.
26. Moglabey YB, Kircheisen R, Seoud M, El Mogharbel N, Van den Veyver I, Slim R. Genetic mapping of a maternal locus responsible for familial hydatidiform moles. Hum Mol Genet 1999;8:667-671.
27. Slim R, Fallahian M, Riviere J-B, Zali MR. Evidence of a genetic heterogeneity of familial hydatidiform moles. Placenta 2005;26:5-9.
28. Panichkul PC, Al-Hussaini TK, Sierra R, et al. Recurrent biparental hydatidiform mole: additional evidence for a 1.1-Mb locus in 19q13.4 and candidate gene analysis. J Soc Gynecol Investig 2005; 12:376-383.
29. Zhao J, Moss J, Sebire NJ, et al. Analysis of the chromosomal region 19q13.4 in two Chinese families with recurrent hydatidiform mole. Hum Reprod 2006;21:536-541.
30. Oikonomopolou K, Scorilas A, Michael IP, et al. Kallikreins as markers of disseminated cells in ovarian cancer: a pilot study. Tumor Biol 2006;27:104-114.
31. Borgono CA, Michael IP, Diamandis EP. Human tissue kallikreins: physiologic roles and applications in cancer. Mol Cancer Res 2004;2: 257-280.
32. Aizawa M, Nakayam M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenit Anom 2002;42:309-317.
33. Weksberg R, Teshima I, Williams BR, et al. Molecular characterization of cytogenetic alterations associated with the Beckwith-Weidemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum Mol Genet 1993;2: 549-556.